1. Home
  2. ALMS vs RCEL Comparison

ALMS vs RCEL Comparison

Compare ALMS & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • RCEL
  • Stock Information
  • Founded
  • ALMS 2021
  • RCEL N/A
  • Country
  • ALMS United States
  • RCEL United States
  • Employees
  • ALMS N/A
  • RCEL N/A
  • Industry
  • ALMS
  • RCEL Medical/Dental Instruments
  • Sector
  • ALMS
  • RCEL Health Care
  • Exchange
  • ALMS NYSE
  • RCEL Nasdaq
  • Market Cap
  • ALMS 260.6M
  • RCEL N/A
  • IPO Year
  • ALMS 2024
  • RCEL N/A
  • Fundamental
  • Price
  • ALMS $5.82
  • RCEL $8.14
  • Analyst Decision
  • ALMS Strong Buy
  • RCEL Buy
  • Analyst Count
  • ALMS 7
  • RCEL 5
  • Target Price
  • ALMS $28.17
  • RCEL $17.25
  • AVG Volume (30 Days)
  • ALMS 1.2M
  • RCEL 194.6K
  • Earning Date
  • ALMS 05-15-2025
  • RCEL 05-12-2025
  • Dividend Yield
  • ALMS N/A
  • RCEL N/A
  • EPS Growth
  • ALMS N/A
  • RCEL N/A
  • EPS
  • ALMS N/A
  • RCEL N/A
  • Revenue
  • ALMS N/A
  • RCEL $64,251,000.00
  • Revenue This Year
  • ALMS N/A
  • RCEL $61.91
  • Revenue Next Year
  • ALMS N/A
  • RCEL $31.36
  • P/E Ratio
  • ALMS N/A
  • RCEL N/A
  • Revenue Growth
  • ALMS N/A
  • RCEL 28.14
  • 52 Week Low
  • ALMS $3.18
  • RCEL $7.51
  • 52 Week High
  • ALMS $13.53
  • RCEL $15.98
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • RCEL 39.91
  • Support Level
  • ALMS N/A
  • RCEL $8.91
  • Resistance Level
  • ALMS N/A
  • RCEL $9.41
  • Average True Range (ATR)
  • ALMS 0.00
  • RCEL 0.49
  • MACD
  • ALMS 0.00
  • RCEL -0.02
  • Stochastic Oscillator
  • ALMS 0.00
  • RCEL 0.60

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.

Share on Social Networks: